Unsupported browser detected
Your browser appears to be unsupported. Because of this, portions of the site may not function as intended.
Please install a current version of Chrome, Firefox, Edge, or Safari for a better experience.
Purpose
to develop a new type of drug for treating human and animal diseases caused by African trypanosomes by identifying unconventional antibodies that bind fixed epitopes on trypanosomes thereby inhibiting their growth.
Grantee
Division
Global Health
Date
APRIL 2014
Region Served
GLOBAL
Committed Amount
$100,000
Grant Topic
Discovery and Translational Sciences
Duration (Months)
7
Grantee Location
Edinburgh, Edinburgh, United Kingdom
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.